Skip to main content
. 2024 May 8;25(10):5112. doi: 10.3390/ijms25105112

Table 2.

Sociodemographic and clinical characteristics according to the genotype.

Variables ABCB1 C1236T Polymorphism ABCB1 C3435T Polymorphism ABCB1 G2677TA Polymorphism
CC CT TT p Value CC CT TT p Value GG GT GA TT TA p Value
Age (mean and SD) 40.6 (10.5) 41.0 (11.4) 38.5 (12.3) 0.807 43.0 (10.7) 40.1 (11.5) 37.1 (10.0) 0.246 41.3 (10.7) 40.2 (11.6) 49.0 38.0 (10.5) 38.3 (15.9) 0.867
Sex, female (%) 18 (56.2) 31 (83.8) 10 (90.9) 0.013 14 (53.2) 30 (76.9) 15 (100) 0.004 18 (56.3) 30 (83.3) 0 (0) 8 (100) 3 (100) 0.009
Number of previous depressive episodes 1.3 (0.5) 1.5 (0.5) 1.5 (0.5) 0.299 1.4 (0.5) 1.5 (0.5) 1.5 (0.5) 0.719 1.3 (0.5) 1.6 (0.5) 1.0 1.5 (0.5) 1.3 (0.6) 0.400
Time to remission (weeks), mean (SD) 16.2 (12.1) 20.0 (11.3) 10.5 (7.1) 0.102 14.9 (12.3) 21.3 (10.9) 10.2 (6.9) 0.027 # 15.6 (12.1) 18.9 (11.0) 16.0 10.0 (7.0) 31.0 (6.2) 0.096
Time to relapse (weeks) mean (SD) 30.6 (13.8) 45.7 (25.2) 19.7 (17.9) 0.177 34.8 (12.1) 31.7 (16.9) 37.0 (37.6) 0.930 30.6 (13.8) 44.9 (23.1) ND 9.5 (4.9) ND 0.077
Total time in the study (weeks) mean (SD) 59.7 (30.5) 67.3 (28.4) 54.3 (33.1) 0.359 34.6 (6.8) 26.1 (4.2) 30.1 (7.8) 0.312 62.8 (32.6) 64.8 (28.5) 95.0 47.6 (28.2) 59.9 (5.6) 0.497
Baseline BDI score, mean (SD) 29.2 (7.6) 27.4 (6.8) 25.3 (8.4) 0.276 29.5 (7.9) 27.6 (6.94) 25.6 (7.4) 0.265 28.8 (7.6) 27.9 (7.2) 24.0 24.5 (8.9) 26.3 (2.5) 0.647
Final BDI score, mean (SD) 16.1 (14.3) 13.0 (10.6) 13.6 (13.2) 0.535 16.6 (15.2) 12.9 (12.7) 14.4 (12.5) 0.497 15.8 (14.6) 13.9 (10.6) 1.0 12.1 (13.1) 16.0 (12.2) 0.762
BDI change, mean (SD) 12.9 (11.1) 14.4 (11.1) 11.6 (8.7) 0.720 12.8 (11.5) 14.7 (10.4) 11.0 (10.3) 0.501 13.0 (11.2) 14.0 (11.1) 23.0 12.4 (8.4) 10.3 (10.4) 0.872

p value: ANOVA test; # Independent-samples Kruskal-Wallis test.